Arrowhead Pharmaceuticals, Inc. (LON:0HI3)
67.80
-1.66 (-2.39%)
Feb 6, 2026, 4:31 PM GMT
Arrowhead Pharmaceuticals Employees
Arrowhead Pharmaceuticals had 711 employees as of September 30, 2025. The number of employees increased by 102 or 16.75% compared to the previous year.
Employees
711
Change (1Y)
102
Growth (1Y)
16.75%
Revenue / Employee
1.14M GBP
Profits / Employee
211.37K GBP
Market Cap
6.69B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 711 | 102 | 16.75% |
| Sep 30, 2024 | 609 | 84 | 16.00% |
| Sep 30, 2023 | 525 | 128 | 32.24% |
| Sep 30, 2022 | 397 | 68 | 20.67% |
| Sep 30, 2021 | 329 | 97 | 41.81% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Genus | 3,190 |
| Oxford Nanopore Technologies | 1,325 |
| Oxford Biomedica | 900 |
| Avacta Group | 151 |
| 4basebio | 110 |
| Scancell Holdings | 60 |
| PureTech Health | 56 |
| SkinBioTherapeutics | 41 |
Arrowhead Pharmaceuticals News
- 10 days ago - Arrowhead (ARWR) Advances with New Atherosclerosis Treatment Trial - GuruFocus
- 10 days ago - Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia - Business Wire
- 15 days ago - Arrowhead Pharma (ARWR): B. Riley Securities Raises Price Target Significantly | ARWR Stock News - GuruFocus
- 16 days ago - Arrowhead Pharma (ARWR) Sees Target Price Boost by HC Wainwright & Co. | ARWR Stock News - GuruFocus
- 16 days ago - Arrowhead Pharmaceuticals to Webcast Fiscal 2026 First Quarter Results - Business Wire
- 22 days ago - ARWR September 18th Options Begin Trading - Nasdaq
- 24 days ago - Arrowhead Pharma (ARWR) Price Target Raised by Piper Sandler | ARWR Stock News - GuruFocus
- 24 days ago - Arrowhead Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript - GuruFocus